Showing results 1 to 20 of 30
next >
| Issue Date | Title | Author(s) |
| 2022-11-22 | Effect of Regular, Low-Dose, Extended-release Morphine on Chronic Breathlessness in Chronic Obstructive Pulmonary Disease: The BEAMS Randomized Clinical Trial. | Ekström, M; Ferreira, D; Chang, S; Louw, S; Johnson, MJ; Eckert, DJ; Fazekas, B; Clark, KJ; Agar, MR; Currow, DC; Australian National Palliative Care Clinical Studies Collaborative, |
| 2022-02-07 | Phase III, international, multicentre, double-blind, dose increment, parallel-arm, randomised controlled trial of duloxetine versus pregabalin for opioid-unresponsive neuropathic cancer pain: a JORTC-PAL16 trial protocol. | Matsuoka, H; Clark, K; Fazekas, B; Oyamada, S; Brown, L; Ishiki, H; Matsuda, Y; Hasuo, H; Ariyoshi, K; Lee, J; Le, B; Allcroft, P; Kochovska, S; Fujiwara, N; Miyaji, T; Lovell, M; Agar, M; Yamaguchi, T; Satomi, E; Iwase, S; Phillips, J; Koyama, A; Currow, DC |
| 2022-01-01 | Opioid-sparing effects of ketorolac in palliative care patients receiving opioids for chronic cancer-related pain: A systematic literature review. | Butcher, B; Hutchings, E; Fazekas, B; Clark, K; Rowett, D; Currow, D |
| 2021-01-28 | A randomised, double blind, placebo-controlled trial of megestrol acetate or dexamethasone in treating symptomatic anorexia in people with advanced cancer | Currow, DC; Glare, P; Louw, S; Martin, P; Clark, K; Fazekas, B; Agar, MR |
| 2021-01-01 | Defining the trials nurses’ role in operationalising a medicinal cannabis clinical trial | Razmovski-Naumovski, V; West, PA; Bellemore, F; Byfieldt, N; Bellamy, D; Chye, R; Clark, K; Martin, JH; Fazekas, B; Phillips, JL; Agar, MR |
| 2020-10-31 | Health-related quality of life in patients with inoperable malignant bowel obstruction: secondary outcome from a double-blind, parallel, placebo-controlled randomised trial of octreotide. | McCaffrey, N; Asser, T; Fazekas, B; Muircroft, W; Agar, M; Clark, K; Eckermann, S; Lee, J; Joshi, R; Allcroft, P; Sheehan, C; Currow, DC |
| 2020-10 | Evaluation of the IMPACCT Rapid Program: A Cross-Sectional Survey of International Site Investigators. | Hunt, J; Brown, L; Fazekas, B; Doogue, M; Rowett, D; Luckett, T; Morgan, D; Reed-Cox, K; Sheehan, C; Tuffin, P; Currow, DC |
| 2020-10 | A Multicomponent Nonpharmacological Intervention to Prevent Delirium for Hospitalized People with Advanced Cancer: A Phase II Cluster Randomized Waitlist Controlled Trial (The PRESERVE Pilot Study). | Hosie, A; Phillips, J; Lam, L; Kochovska, S; Noble, B; Brassil, M; Kurrle, S; Cumming, A; Caplan, GA; Chye, R; Ely, EW; Lawlor, PG; Bush, SH; Davis, JM; Lovell, M; Parr, C; Williams, S; Hauser, K; McArdle, S; Jacquier, K; Phillipson, C; Kuwahata, L; Kerfoot, J; Brown, L; Fazekas, B; Cheah, SL; Edwards, L; Green, A; Hunt, J; Attwood, R; Assen, T; Garcia, M; Wilcock, J; Agar, M |
| 2020-05 | A randomized, double-blind, crossover, dose ranging study to determine the optimal dose of oral opioid to treat breakthrough pain for patients with advanced cancer already established on regular opioids. | Currow, DC; Clark, K; Louw, S; Fazekas, B; Greene, A; Sanderson, CR |
| 2020-03-01 | Controlled-Release Oxycodone vs. Placebo in the Treatment of Chronic Breathlessness—A Multisite Randomized Placebo Controlled Trial | Ferreira, DH; Louw, S; McCloud, P; Fazekas, B; McDonald, CF; Agar, MR; Clark, K; McCaffrey, N; Ekström, M; Currow, DC |
| 2020-01 | Assessing quality of life in palliative care settings: head-to-head comparison of four patient-reported outcome measures (EORTC QLQ-C15-PAL, FACT-Pal, FACT-Pal-14, FACT-G7). | King, MT; Agar, M; Currow, DC; Hardy, J; Fazekas, B; McCaffrey, N |
| 2020 | No excess harms from sustained-release morphine: a randomised placebo-controlled trial in chronic breathlessness. | Johnson, MJ; Sbizzera, I; Fairhurst, C; Fazekas, B; Agar, M; Ekstrom, M; Currow, DC |
| 2019-12-01 | Low agreement between mMRC rated by patients and clinicians: Implications for practice | Ekström, M; Chang, S; Johnson, MJ; Fazekas, B; Kochovska, S; Huang, C; Currow, DC |
| 2019-11-01 | A Randomized, Double-Blind, Multisite, Pilot, Placebo-Controlled Trial of Regular, Low-Dose Morphine on Outcomes of Pulmonary Rehabilitation in COPD | Kochovska, S; Fazekas, B; Hensley, M; Wheatley, J; Allcroft, P; Currow, DC |
| 2019-09-01 | Harms From Haloperidol for Symptom Management in Palliative Care—a Post Hoc Pooled Analysis of Three Randomized Controlled Studies and Two Consecutive Cohort Studies | Matsuoka, H; Agar, M; Vandersman, Z; Good, P; Fazekas, B; Brown, L; Hardy, J; Weil, J; Currow, DC |
| 2019-04-01 | Oral dexamethasone in the management of cancer-related pain: A feasibility study | Eastman, P; Currow, DC; Fazekas, B; Brown, L; Le, B |
| 2019-01-01 | Multicomponent non-pharmacological intervention to prevent delirium for hospitalised people with advanced cancer: Study protocol for a phase II cluster randomised controlled trial | Hosie, A; Phillips, J; Lam, L; Kochovska, S; Noble, B; Brassil, M; Kurrle, SE; Cumming, A; Caplan, GA; Chye, R; Le, B; Ely, EW; Lawlor, PG; Bush, SH; Davis, JM; Lovell, M; Brown, L; Fazekas, B; Cheah, SL; Edwards, L; Agar, M |
| 2019-01-01 | Comparability of the Australian National Cancer Symptom Trials (CST) Group's Study Populations to National Referrals to Non-CST Specialist Palliative Care Services Participating in the Palliative Care Outcomes Collaboration | Matsuoka, H; Allingham, S; Fazekas, B; Brown, L; Vandersman, Z; Clark, K; Agar, MR; Currow, DC |
| 2019-01-01 | Sertraline in symptomatic chronic breathlessness: a double blind, randomised trial | Currow, DC; Ekström, M; Louw, S; Hill, J; Fazekas, B; Clark, K; Davidson, PM; McDonald, C; Sajkov, D; McCaffrey, N; Doogue, M; Abernethy, AP; Agar, M |
| 2019-01-01 | Economic evaluation of the randomised, double-blind, placebo-controlled study of subcutaneous ketamine in the management of chronic cancer pain | McCaffrey, N; Flint, T; Kaambwa, B; Fazekas, B; Rowett, D; Currow, DC; Hardy, J; Agar, MR; Quinn, S; Eckermann, S |
